Directory

>

Debora Bonenfant

avatar

Debora Bonenfant

Vice-President, Head of Proteomics | Monte Rosa Therapeutics

Basel, Basel-City, Switzerland

View contact details (it's free)

Debora Bonenfant

Summary

Debora Bonenfant is an accomplished VP and Global Head of Proteomics at Monte Rosa Therapeutics, with over twenty years of experience in drug discovery within the pharmaceutical and biotech industries. She has a robust expertise in biochemistry and proteomics, having developed innovative approaches to support early discovery targets across various therapeutic areas. Debora's career is marked by her leadership in building a Proteomics platform and her contributions to significant projects in drug discovery. She has received the Novartis Catalyst Award for her outstanding work. Fluent in English, Spanish, and French, she is well-equipped to navigate international collaborations. Her academic background includes a PhD from the University of Basel, where she specialized in biochemistry. Debora is not only a key player in her field but also actively contributes to scientific literature, showcasing her commitment to advancing proteomics research.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Debora Bonenfant

Work Experience

company logo

Vice-President, Head of Proteomics at

Monte Rosa Therapeutics

March 2023 - Present

company logo

Senior Director at

Monte Rosa Therapeutics

March 2022 - Present

company logo

Director of Proteomics at

Monte Rosa Therapeutics

September 2019 - February 2022

company logo

Senior Research Investigator at

Novartis

January 2014 - November 2021

💼

Member of board at

Swiss Proteomics Society

January 2017 - November 2021

company logo

Research Investigator at

Novartis

December 2006 - January 2014

company logo

Post-Doctoral Fellow at

Novartis Institutes For Biomedical Research

November 2003 - November 2007

Logos provided by Logo.dev

Debora Bonenfant

Education

University of Basel, Biozentrum, Doctor Of Philosophy (Phd)

January 1999 - January 2003

University of Toulouse , Dea (Masters Degree)

January 1998 - January 1999

Frequently Asked Questions about Debora Bonenfant

What is Debora Bonenfant email address?

Debora Bonenfant's primary email address is **********@monterosatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Debora Bonenfant work for?

Debora Bonenfant is a Vice-President, Head of Proteomics at Monte Rosa Therapeutics, a company specializing in Commercial physical research.

Where Debora Bonenfant graduated from?

Debora Bonenfant holds a degree in Biochemistry from University of Basel, Biozentrum.

How can I directly contact Debora Bonenfant?

To contact Debora Bonenfant directly, you can use the email address **********@monterosatx.com. Complete contact information is available upon registration with Muraena.

Who is Debora Bonenfant?

Debora Bonenfant is an accomplished VP and Global Head of Proteomics at Monte Rosa Therapeutics, with over twenty years of experience in drug discovery within the pharmaceutical and biotech industries. She has a robust expertise in biochemistry and proteomics, having developed innovative approaches to support early discovery targets across various therapeutic areas. Debora's career is marked by her leadership in building a Proteomics platform and her contributions to significant projects in drug discovery. She has received the Novartis Catalyst Award for her outstanding work. Fluent in English, Spanish, and French, she is well-equipped to navigate international collaborations. Her academic background includes a PhD from the University of Basel, where she specialized in biochemistry. Debora is not only a key player in her field but also actively contributes to scientific literature, showcasing her commitment to advancing proteomics research.

Debora`s contact details

mail

**********@monterosatx.com

Colleagues

avatar
Filip Janku

Chief Medical Officer

avatar
Ed Dunn

VP - Corporate Controller, Principal Accounting Officer

avatar
Karin Von Hodenberg

Vice President of Quality

avatar
Bernhard Fasching

Vice President, Chemistry at Monte Rosa Therapeutics

avatar
Ralph Tiedt

VP Oncology

avatar
Kevin Lumb

Vice President, Discovery Sciences

avatar
Chris King

VP of Nonclinical Development & Clinical Pharmacology

avatar
John Castle

Chief Information Officer

avatar
Jennifer Champoux

Chief Operating Officer

avatar
Alison Paterson

Vice President

View Contact details (it's free)
Request Profile Removal